We are live on ! Find out more

421 hedge funds and large institutions have $6.58B invested in Chemed in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 154 increasing their positions, 149 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 149

3% more call options, than puts

Call options by funds: $8.25M | Put options by funds: $8M

0.86% less ownership

Funds ownership: 90.38%89.51% (-0.86%)

5% less funds holding

Funds holding: 442421 (-21)

14% less capital invested

Capital invested by funds: $7.66B → $6.58B (-$1.08B)

30% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 67

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
421
Holders Change
-21
Holders Change %
-4.75%
% of All Funds
7.39%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
47
Increased
154
Reduced
149
Closed
67
Calls
$8.25M
Puts
$8M
Net Calls
+$246K
Net Calls Change
-$5.13M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
$7.61M
TCMG
102
TSP Capital Management Group
New Jersey
$7.38M
Ensign Peak Advisors
103
Ensign Peak Advisors
Utah
$7.29M +$445K +908 +6%
Holocene Advisors
104
Holocene Advisors
New York
$7.2M +$6.14M +12,531 +400%
MOACM
105
Mutual of America Capital Management
New York
$7.1M -$176K -360 -2%
Nordea Investment Management
106
Nordea Investment Management
Sweden
$6.96M -$109K -223 -1%
WCA
107
Waratah Capital Advisors
Ontario, Canada
$6.9M +$7.36M +15,004 New
D.E. Shaw & Co
108
D.E. Shaw & Co
New York
$6.87M +$4.95M +10,107 +209%
ACA
109
Aptus Capital Advisors
Alabama
$6.84M +$189K +386 +3%
OC
110
Oppenheimer & Co
New York
$6.36M +$226K +461 +3%
GF
111
Gabelli Funds
New York
$6.35M -$2.06M -4,200 -23%
CSS
112
Cubist Systematic Strategies
Connecticut
$6.27M +$6.09M +12,426 +1,032%
QI
113
QS Investors
New York
$6.12M -$4.05M -8,252 -38%
Capital Fund Management (CFM)
114
Capital Fund Management (CFM)
France
$6.08M -$2.97M -6,051 -31%
KTA
115
Keeley-Teton Advisors
Illinois
$5.97M +$682K +1,391 +12%
State of Tennessee, Department of Treasury
116
State of Tennessee, Department of Treasury
Tennessee
$5.64M -$1.64M -3,348 -21%
TPSF
117
Texas Permanent School Fund
Texas
$5.51M -$620K -1,265 -10%
MCM
118
McKinley Capital Management
Alaska
$5.33M
US Bancorp
119
US Bancorp
Minnesota
$5.31M +$264K +538 +5%
BG
120
Bahl & Gaynor
Ohio
$4.88M +$126K +258 +2%
KeyBank National Association
121
KeyBank National Association
Ohio
$4.64M -$187K -382 -4%
Comerica Bank
122
Comerica Bank
Texas
$4.62M -$219K -447 -4%
Ohio Public Employees Retirement System (OPERS)
123
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.58M +$219K +447 +5%
Lazard Asset Management
124
Lazard Asset Management
New York
$4.55M +$525K +1,071 +12%
CIM
125
Contravisory Investment Management
Massachusetts
$4.54M -$190K -387 -4%

CHE Hedge Fund Activity: Q1 2021 in Review

421 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q1 2021, worth a combined $6.58B — down 14% from $7.66B a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of CHE and 47 opened new positions — a net loss of 20 holders — while 149 trimmed existing stakes and 154 added.

The largest buyer was Schwartz Investment Counsel, adding an estimated $34.9M. The largest seller was Wells Fargo, cutting an estimated $50.6M.

  • 421 institutional investors held Chemed (CHE) as of Q1 2021, down from 442 in Q4 2020.
  • Funds reported $6.58B of Chemed stock for Q1 2021, down 14% quarter-over-quarter.
  • 47 funds opened new Chemed positions in Q1 2021 and 67 closed out, a net change of -20 holders.
  • The largest Chemed buyer in Q1 2021 was Schwartz Investment Counsel, an estimated $34.9M added.
  • The largest Chemed seller in Q1 2021 was Wells Fargo, an estimated $50.6M sold.

Based on aggregated 13F filings for Q1 2021.